Moleculin Biotech, Inc. (MBRX) Stock price, Description, News & Info

#ThinkSabio Latest News

Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107